Katherine Stueland
Amministratore Delegato presso GENEDX HOLDINGS CORP.
Patrimonio netto: 847 457 $ in data 30/04/2024
Posizioni attive di Katherine Stueland
Società | Posizione | Inizio | Fine |
---|---|---|---|
GENEDX HOLDINGS CORP. | Direttore/Membro del Consiglio | 29/04/2022 | - |
Amministratore Delegato | 29/04/2022 | - | |
Presidente | - | - | |
Cancan Health | Direttore/Membro del Consiglio | - | - |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Part of GeneDx Holdings Corp., GeneDx LLC is a leader in clinical genomics and rare disease. The company is based in Stamford, CT. GeneDx was founded in 2000. GeneDx is known for its unparalleled database, deep clinical knowledge, and expertise in variant interpretation. The CEO is Katherine A. Stueland. | Amministratore Delegato | 01/06/2021 | - |
Presidente | 01/06/2021 | - | |
Mount Sinai Genomics, Inc.
Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Direttore/Membro del Consiglio | - | - |
Presidente | - | - |
Storia della carriera di Katherine Stueland
Precedenti posizioni note di Katherine Stueland
Società | Posizione | Inizio | Fine |
---|---|---|---|
INVITAE CORPORATION | Contatto Relazioni con gli Investitori | 01/01/2014 | 01/10/2016 |
Public Communications Contact | 01/01/2014 | 01/10/2016 | |
Corporate Officer/Principal | 01/10/2016 | 18/06/2021 | |
Vivo Communications, LLC
Vivo Communications, LLC Specialty TelecommunicationsCommunications Vivo Communications, LLC provides telecommunication services. The private company is based in Seattle, WA. | Corporate Officer/Principal | 01/01/2013 | 01/12/2013 |
DENDREON CORPORATION | Contatto Relazioni con gli Investitori | 23/08/2011 | 01/06/2012 |
GeneDx, Inc.
GeneDx, Inc. Medical/Nursing ServicesHealth Services GeneDx, Inc. provides genetic testing for rare hereditary disorders. It offers diagnostic tests for gene, disease, mitochondria, inherited metabolic, and eye disorders; gene deletion/duplication analysis services; and molecular cytogenetic, prenatal genetic, mutation-specific, autism/autism spectrum disorder, cardiology genetic, and mutation confirmation tests. The company was founded by John Compton and Sherri Bale in 2000 and is headquartered in Gaithersburg, MD. | Amministratore Delegato | 01/01/2021 | - |
Presidente | 01/01/2021 | - | |
Rivkin Center for Ovarian Cancer
Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Rivkin Center for Ovarian Cancer is a non-profit organization that funds ovarian cancer research, screening, and educational programs for women. The company was founded by Saul E. Rivkin in 1996 and is headquartered in Seattle, WA. | Direttore/Membro del Consiglio | - | - |
Formazione di Katherine Stueland
Miami University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 11 |
Posizioni
President | 4 |
Director/Board Member | 4 |
Chief Executive Officer | 3 |
Settori
Health Services | 6 |
Health Technology | 2 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
INVITAE CORPORATION | Health Services |
GENEDX HOLDINGS CORP. | Health Services |
Aziende private | 7 |
---|---|
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Cancan Health | |
Rivkin Center for Ovarian Cancer
Rivkin Center for Ovarian Cancer Miscellaneous Commercial ServicesCommercial Services Rivkin Center for Ovarian Cancer is a non-profit organization that funds ovarian cancer research, screening, and educational programs for women. The company was founded by Saul E. Rivkin in 1996 and is headquartered in Seattle, WA. | Commercial Services |
Vivo Communications, LLC
Vivo Communications, LLC Specialty TelecommunicationsCommunications Vivo Communications, LLC provides telecommunication services. The private company is based in Seattle, WA. | Communications |
GeneDx, Inc.
GeneDx, Inc. Medical/Nursing ServicesHealth Services GeneDx, Inc. provides genetic testing for rare hereditary disorders. It offers diagnostic tests for gene, disease, mitochondria, inherited metabolic, and eye disorders; gene deletion/duplication analysis services; and molecular cytogenetic, prenatal genetic, mutation-specific, autism/autism spectrum disorder, cardiology genetic, and mutation confirmation tests. The company was founded by John Compton and Sherri Bale in 2000 and is headquartered in Gaithersburg, MD. | Health Services |
GeneDx LLC
GeneDx LLC Medical/Nursing ServicesHealth Services Part of GeneDx Holdings Corp., GeneDx LLC is a leader in clinical genomics and rare disease. The company is based in Stamford, CT. GeneDx was founded in 2000. GeneDx is known for its unparalleled database, deep clinical knowledge, and expertise in variant interpretation. The CEO is Katherine A. Stueland. | Health Services |
Mount Sinai Genomics, Inc.
Mount Sinai Genomics, Inc. Medical/Nursing ServicesHealth Services Mount Sinai Genomics, Inc. operates online predictive health analysis platform for diagnosis, treatment and prevention of diseases. It offers Centrellis which analyzes and interprets extensive information about known inherited diseases, including related mutations, frequency across populations, and the penetrance and expressivity of genetic changes. The company was founded by Eric Schadt and is headquartered in Stamford, CT. | Health Services |
- Borsa valori
- Insiders
- Katherine Stueland
- Esperienza